Speciality: Pulmonary Medicine
Description:
A warm welcome to all the medical professionals in this interesting session on Asthma: Is living with it easy?
Living with asthma can be challenging, but it is manageable with proper care. Asthma causes inflammation and narrowing of the airways, leading to symptoms like wheezing, shortness of breath, and coughing. These symptoms can range from mild to severe, and they often require lifelong management. Medications such as inhalers and steroids, along with lifestyle changes, help keep asthma under control.
However, living with asthma can be difficult, especially during flare-ups triggered by allergens, exercise, or stress. Managing asthma requires awareness of triggers, regular check-ups, and adherence to treatment. While it may limit certain activities, with proper care, many people lead normal, active lives despite the condition.
Therefore, get an overall knowledge of asthma: is living with it easy?
See More Webinars @ Hidoc Webinars
1.
Examines Office-Based Transperineal Prostate Biopsies Methodology.
2.
A global study demonstrates that screening for lung cancer significantly raises the long-term survival rate.
3.
Is a $2,000 Whole-Body MRI Worth It?
4.
Surgery may not be necessary to treat invasive breast cancer
5.
Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.
1.
Understanding Evans Syndrome: Causes, Symptoms, and Treatment Options
2.
Understanding Sepsis and Precision-Medicine-Based Immunotherapy: A Pathophysiological Perspective
3.
Exploring The Science Of Hematopoietic Stem Cell Transplantation: What You Need To Know
4.
Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post
5.
Understanding Lymphedema: Symptoms, Causes, and Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
2.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
4.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation